Justicia procumbens extract inhibits IgE secretion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for allergic diseases are limited by side effects and inefficacy, with a need for new therapeutic agents that can safely and effectively address a range of allergic conditions.
Innovation Solution
A pharmaceutical, food, and cosmetic composition using an extract of the Justicia genus, specifically Justicia procumbens L., which inhibits IgE antibody secretion and degranulation of mast cells and basophils, providing anti-allergic effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments for allergic diseases are used, then allergic symptoms can be suppressed, but side effects occur and efficacy is limited
Solution Approach 1:
The patent extracts and utilizes specific active components from the Justicia procumbens plant, isolating the beneficial anti-allergic properties from the whole plant material. This extraction principle allows for targeted therapeutic action while potentially reducing unwanted side effects associated with conventional treatments.
Solution Approach 2:
The Justicia procumbens extract acts as an intermediary substance that mediates the treatment of allergic diseases. It provides an alternative therapeutic pathway between the patient and conventional medications, offering a natural compound-based solution that addresses both efficacy and safety concerns.
2Reliability
If new therapeutic agents are developed, then safety and effectiveness can be improved, but research and development time is required
Solution Approach 1:
The patent leverages the traditional use of Justicia procumbens in folk medicine as preliminary evidence of safety and efficacy. This pre-existing knowledge base accelerates the drug development process by providing initial validation before formal clinical trials, reducing the overall development time while maintaining safety standards.
Solution Approach 2:
The Justicia procumbens plant serves as a self-validating source through its historical use in treating allergic conditions. The plant's long-standing presence in traditional medicine systems provides inherent validation of its safety profile, reducing the need for extensive preliminary safety testing and accelerating development.
Data Source
Figure 1
AI summary
The present invention relates to a pharmaceutical composition, food composition and cosmetic composition for preventing, treating, or improving allergic diseases comprising extract or fraction of a plant of the Justicia genus as an active ingredient. The extract or a fraction of a plant of the Justicia genus according to the present invention can inhibit IgE antibody secretion and the degranulation of mast cells and basophils, and exhibits an excellent anti-allergic effect, and thus can effectively prevent, treat, or improve allergic diseases.